2025 10^th Asian Pacific Congress on Bronchology and Interventional Pulmonology and 2025 Summer Workshop of Taiwan Society of Pulmonary and Critical Care Medicine at NTUH International Convention Centre from 20 – 22 June 2025

The 2025 10th Asian Pacific Congress on Bronchology and Interventional Pulmonology (APCB), held in conjunction with the 2025 Summer Workshop of the Taiwan Society of Pulmonary and Critical Care Medicine, serves as a premier academic and clinical platform that brings together leading experts, clinicians, and researchers in thoracic medicine from across the Asia-Pacific region and beyond. This distinguished gathering fosters the exchange of cutting-edge knowledge, best practices, and innovations in interventional pulmonology.

First Pharma is deeply honoured to have been invited by Gongwin Biopharm to participate in this esteemed event. This opportunity allows us to gain deeper insights into key areas such as interventional pulmonology, airway obstruction management, and navigational bronchoscopy—fields that are rapidly evolving and critical to the advancement of pulmonary care.

Beyond the scientific exchange, this visit also provides a valuable occasion to strengthen our relationship with Dr. Leong Swee Wei and Gongwin Biopharm, to better understand their innovative product, Para-Toluenesulfonamide (PTS), and its clinical potential. We are eager to explore its application and relevance within our own healthcare landscape.

We hope that through this experience, we will not only broaden our technical and clinical understanding but also bring back new perspectives and knowledge to Malaysia.

Anaesthesia Patient Safety Symposium combined with Regional Obesity & Bariatric Anaesthesia Conference 2025 at Waterfront Hotel, Kuching, Sarawak from 20-22 June 2025

We are honoured to participate as the main exhibitor at this prestigious event. It is a privilege to once again collaborate with Dr. Peter Tan, whose continued partnership reinforces our shared commitment to advancing clinical knowledge and improving patient care.

Our presence at this event underscores our ongoing efforts to raise greater awareness about the clinical significance of our Phenylephrine pre-filled syringe (PFS). While its established role in general anaesthesia is well recognized, we are also dedicated to highlighting its emerging importance in specialized areas such as obesity and bariatric anaesthesia—fields where precision, safety, and rapid responsiveness are of critical importance.

Through this platform, we aim to engage with anaesthesia professionals, share insights, and foster meaningful discussions that contribute to better patient outcomes.

AGUETTANT Partnering Summit in Asia - Ho Chi Minh City, Vietnam

We are honoured to be invited to the Partnering Summit in Asia, hosted by Aguettant, taking place on 14–15 May 2025 in Ho Chi Minh City, Vietnam. This exclusive event is dedicated to exploring new opportunities for Aguettant’s essential and innovative product portfolio, with a focus on driving strategic growth in the coming year.

In preparation for the summit, we participated in the pre-meeting webinar, which provided valuable insights into Aguettant’s latest products, market potential, and key business intelligence relevant to our operations.

We look forward to attending the main event, where we will engage in meaningful discussions, exchange ideas, and further strengthen our partnership with Aguettant - paving the way for mutual success and long-term collaboration in the region.

Neuroanaesthesia Symposium 2025 at Sabah International Convention Centre, Kota Kinabalu from 16-18 May 2025

First Pharmaceutical is proud to participate in the Neuroanaesthesia Symposium (NAS) 2025. This prestigious biennial event was first initiated in 2010 by the Special Interest Group in Neuroanaesthesia under the College of Anaesthesiologists, Academy of Medicine of Malaysia. Since its inception, the symposium has seen a steady increase in participation, reflecting its growing importance in the field. NAS 2025 is jointly organised by the Malaysian Society of Neuroanaesthesiology and Neurocritical Care (MSNACC), the Society of Neuroscience in Anesthesiology and Critical Care (SNACC), the NeuroAnaesthesia and Critical Care Society (NACCS), UK, and the Sabah Academic Society of Anaesthesiology (PERAKAS).

We are excited to showcase our Prefilled Syringe (PFS) technology to the Malaysian market, underscoring our commitment to advancing neurocritical care and improving patient outcomes. This platform offers us a valuable opportunity to engage with global industry leaders, foster collaboration, and contribute to meaningful innovations in the field.

We are especially pleased to connect with Dr. Peter Tan, Organising Chair of NAS 2025 and President of the Malaysian Society of Neuroanaesthesiology and Neurocritical Care, and UMS senior medical lecturer, Dr. Yeap Boon Tat in supporting the continued growth of neuroanaesthesia in Malaysia and beyond.

The First Pharma team is excited to participate as a Gold Sponsor for this event, held at Sabah International Convention Centre, Kota Kinabalu, Sabah, from 16-18 August 2024.

We are very pleased to invite Prof. Dr. Maevskaya, Gastroenterologist and Hepatologist at the I.M. Sechenov First Moscow State Medical University Hospital as a sponsored speaker to share her valuable experiences regarding UDCA in preventing atherosclerosis, steatosis and liver fibrosis in MASLD (NAFLD) patients.

We are honoured to have the chance to take photo with the current MSGH president, Datuk Dr Raman at the event.

We look forward to continuing these meaningful collaborations between Prof. Dr. Maevskaya and MSGH!

We are excited to participate as one of the gold sponsors at the MSA-CoA-AMM Annual Scientific Congress 2024. A special thanks to Mr. Long and Ms. Thi from Aguettant Ho Chi Minh for their invaluable support. With their assistance, we are excited to welcome Dr. Nguyen Ngoc Tho from Hanoi French Hospital, who will be presenting a talk on “Hypotension During C-Section Under Spinal Anaesthesia: Current Management Trends.” Dr. Tho is thrilled to share his valuable experiences and practices from Vietnam. We truly appreciate Mr. Long and Ms. Thi for their efforts in helping to make this event a success!

The First Pharma team recently had the opportunity to visit Aguettant Asia Pacific office in Ho Chi Minh City from 12-16 March 2024. We met with the Aguettant Vietnam key team for a thorough discussion on our business and marketing plans.

Additionally, we were honoured to visit several key opinion leaders (KOLs) in anaesthesiology department at few of the main hospitals, where we gained valuable insights from their experiences using Phenylephrine PFS. This visit has strengthened our collaborations and enhanced our understanding of the needs within the field.